Preoperative Cytopenia in Patients Affected by High‐Risk Neuroblastoma: Just a Matter of Platelets?
Anemia, neutropenia, and platelets between 100 × 10<sup>3</sup>/µL and 50 × 10<sup>3</sup>/µL are not contraindications to elective major surgery in patients with HR-NB. The risk of surgical complications in patients with platelets less than 50 × 10<sup>3</sup>/µL has to be balanced against the risk of long delay in surgical treatment.
Authors
- Giorgio Persano (ORCID: https://orcid.org/0000-0002-8093-2726)
- Pier Luigi Di Paolo (ORCID: https://orcid.org/0000-0001-5641-6169)
- Maria Antonietta De Ioris (ORCID: https://orcid.org/0000-0002-2113-4505)
- Gian Luigi Natali (ORCID: https://orcid.org/0000-0002-0758-0699)
- Valerio Voglino (ORCID: https://orcid.org/0000-0001-7551-7782)
- Carmen Malaspina
- Alessandro Crocoli (ORCID: https://orcid.org/0000-0003-2157-4233)
- Cristina Martucci (ORCID: https://orcid.org/0000-0002-0037-4534)
- Chiara Grimaldi
- Francesca Del Bufalo (ORCID: https://orcid.org/0000-0001-9643-3465)
- F. Fabozzi (ORCID: https://orcid.org/0000-0001-9821-4151)
- Simone Reali
- Federico Beati
- Annalisa Serra
Institutions
- University of Rome Tor Vergata (IT)
- Agostino Gemelli University Polyclinic (IT)
- University Hospital Foundation (CA)
- Bambino Gesù Children's Hospital (IT)
- Santobono Children's Hospital (IT)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1002/1545-5017.70071
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministero della Salute